 Parent Directory | | |
 PFR_COVID19_200302_BIS on financial impact of COVID.pdf | 2023-03-12 11:15 | 328k |
| PFR_COVID19_200306_DECRETO-LEGGE 2 marzo 2020, n. 9. Italy regional assitance... | 2023-03-12 11:15 | 2356k |
| PFR_COVID19_200306_italy sources.docx | 2023-03-12 11:15 | 15k |
| PFR_COVID19_200306_Italy stimulus package.docx | 2023-03-12 11:15 | 123k |
| PFR_COVID19_200306_Italy stimulus package_afternoon memo.docx | 2023-03-12 11:15 | 17k |
| PFR_COVID19_200308_DECRETO DEL PRESIDENTE DEL CONSIGLIO DEI MINISTRI 8 marzo ... | 2023-03-12 11:15 | 1695k |
| PFR_COVID19_200310_Coronavirus action plan UK.pdf | 2023-03-12 11:15 | 263k |
| PFR_COVId19_200310_Coronavirus outbreak what are the economic implications.pdf | 2023-03-12 11:15 | 6896k |
| PFR_COVID19_200310_le repubblica artykul measures under study by the governme... | 2023-03-12 11:15 | 16k |
| PFR_COVID19_200311_Copy of COVID-19-geographic-disbtribution-worldwide-2020-0... | 2023-03-12 11:15 | 656k |
| PFR_COVID19_200314_ECB i BOE.docx | 2023-03-12 11:15 | 17k |
| PFR_COVID19_200317_Association between 2019-nCoV transmission and N95 respira... | 2023-03-12 11:15 | 29k |
| PFR_COVID19_200318_Early dynamics of transmission and control of COVID-19 a m... | 2023-03-12 11:15 | 366k |
| PFR_COVID19_200318_Impact of non-pharmaceutical interventions (NPIs) to reduc... | 2023-03-12 11:15 | 722k |
| PFR_COVID19_200318_„dekret Cura Italia.docx | 2023-03-12 11:15 | 19k |
| PFR_COVID19_200318_„dekret Cura Italia.pdf | 2023-03-12 11:15 | 1090k |
| PFR_COVID19_200319_COVID-19 and Italy what next.pdf | 2023-03-12 11:15 | 474k |
| PFR_COVID19_200319_COVID-19 towards controlling of a pandemic.pdf | 2023-03-12 11:15 | 57k |
| PFR_COVID19_200319_How will country-based mitigation measures influence the.pdf | 2023-03-12 11:15 | 207k |
| PFR_COVID19_200319_Mass masking in the COVID-19 epidemic people need guidance... | 2023-03-12 11:15 | 32k |
| PFR_COVID19_200319_Spain_Real Decreto por COVID19.pdf | 2023-03-12 11:15 | 373k |
| PFR_COVID19_200319_The EU must support the member at the centre of the COVID-... | 2023-03-12 11:15 | 115k |
| PFR_COVID19_200319_The resilience of the Spanish health system against the CO... | 2023-03-12 11:15 | 54k |
| PFR_COVID19_200319_WHO re intrnational travel.docx | 2023-03-12 11:15 | 105k |
| PFR_COVID19_200320_doniesienia ZBH tydzien 12.docx | 2023-03-12 11:15 | 30k |
| PFR_COVID19_200322_Aggiornamento nazionale 19marzo 2020.pdf | 2023-03-12 11:15 | 1361k |
| PFR_COVID19_200322_The possible macroeconomic impact on the UK of an influenz... | 2023-03-12 11:15 | 129k |
| PFR_COVID19_200324_google serach re zalozenie i zawiezenie dzialalnosci.docx | 2023-03-12 11:15 | 320k |
| PFR_COVID19_200324_Social distancing strategies for curbing the COVID-19 epid... | 2023-03-12 11:15 | 2211k |
| PFR_COVID19_200324_U.S. Jobless Rate May Soar to 30%, Fed’s Bullard Says.docx | 2023-03-12 11:15 | 78k |
| PFR_COVID19_200325_Coronavirus disease 2019 the harms of exaggerated informat... | 2023-03-12 11:15 | 557k |
| PFR_COVID19_200325_cytaty z literatury.docx | 2023-03-12 11:15 | 1102k |
| PFR_COVID19_200325_czego nie wiemy o chorobie a co jest wazne ekonomicznie.docx | 2023-03-12 11:15 | 22k |
| PFR_COVID19_200325_Economists' Statement on Support for Jobs and Businesses i... | 2023-03-12 11:15 | 16k |
| PFR_COVID19_200325_Some thoughts on economics and policy at the time of the.pdf | 2023-03-12 11:15 | 141k |
| PFR_COVID19_200326_Il y aura un «après coronavirus».pdf | 2023-03-12 11:15 | 6345k |
| PFR_COVID19_200326_Stefan Kawalec Jak przejść przez epidemię iprzygotować... | 2023-03-12 11:15 | 179k |
| PFR_COVID19_200327_Estimated Influenza Disease Burden.pptx | 2023-03-12 11:15 | 1447k |
| PFR_COVID19_200328_1The Unprecedented Stock MarketReaction to COVID-19.pdf | 2023-03-12 11:15 | 1676k |
| PFR_COVID19_200328_Case fatality risk of influenza A(H1N1pdm09) a systematic ... | 2023-03-12 11:15 | 866k |
| PFR_COVID19_200328_COVID-19 extending or relaxing distancing control measures... | 2023-03-12 11:15 | 45k |
| PFR_COVID19_200328_COVID-19 in Europe the Italian Lesson.pdf | 2023-03-12 11:15 | 179k |
| PFR_COVID19_200328_COVID-19 infection in children.pdf | 2023-03-12 11:15 | 128k |
| PFR_COVID19_200328_Deciphering the power of isolation in controlling COVID-19... | 2023-03-12 11:15 | 49k |
| PFR_COVID19_200328_Early in the epidemic impact of preprints on global discou... | 2023-03-12 11:15 | 190k |
| PFR_COVID19_200328_Rational use of face masks in the COVID-19 pandemic.pdf | 2023-03-12 11:15 | 99k |
| PFR_COVID19_200328_The first infant case of COVID-19 acquired from a secondar... | 2023-03-12 11:15 | 591k |
| PFR_COVID19_200328_The first infant case of COVID-19 acquired from a secondar... | 2023-03-12 11:15 | 599k |
| PFR_COVID19_200328_The Italian health system and the COVID-19 challenge.pdf | 2023-03-12 11:15 | 36k |
| PFR_COVID19_200328_The many estimates of the COVID-19 case fataity rate.pdf | 2023-03-12 11:15 | 47k |
| PFR_COVID19_200329_A Simple Planning Problem for COVID19 lockdown.pdf | 2023-03-12 11:15 | 641k |
| PFR_COVID19_200329_An SEIR Infectious Disease Model with Testing and Conditio... | 2023-03-12 11:15 | 1895k |
| PFR_COVID19_200329_Data Gaps and the Policy Response to the Novel Coronavirus... | 2023-03-12 11:15 | 439k |
| PFR_COVID19_200329_Germany Has Relatively Few Deaths From Coronavirus.docx | 2023-03-12 11:15 | 134k |
| PFR_COVID19_200329_Joint statement by the Financial Conduct Authority (FCA), ... | 2023-03-12 11:15 | 488k |
| PFR_COVID19_200329_Mitigating the COVID - VOX Book.pdf | 2023-03-12 11:15 | 3800k |
| PFR_COVID19_200329_The GlobalImpact of COVID-19and Strategies for Mitiga... | 2023-03-12 11:15 | 1229k |
| PFR_COVID19_200329_What will be the economic impact of COVID19 in the US. ROu... | 2023-03-12 11:15 | 813k |
| PFR_COVID19_200329_‘Coronavirus Aid, Relief, and Economic Security Act�... | 2023-03-12 11:15 | 934k |
| PFR_COVID19_200330_Corona and Financial Stability 2.0 act jointly now but als... | 2023-03-12 11:15 | 446k |
| PFR_COVID19_200330_COVID-19 and the Economy – Micro and Macro Perspectives.pdf | 2023-03-12 11:15 | 389k |
| PFR_COVID19_200330_Pandemics Depress the Economy, Public Health Interventions... | 2023-03-12 11:15 | 2170k |
| PFR_COVID19_200330_Social distancing strategies for curbing the COVID-19 epid... | 2023-03-12 11:15 | 2156k |
| PFR_COVID19_200330_Switzerland can erase the economic cost of Covid19..pdf | 2023-03-12 11:15 | 39k |
| PFR_COVID19_200330_The Coronavirus and Financial Stability.pdf | 2023-03-12 11:15 | 995k |
| PFR_COVID19_200330_The real death toll for Covid.docx | 2023-03-12 11:15 | 16k |
| PFR_COVID19_200330_The role of multinational taxation in the first reversal o... | 2023-03-12 11:15 | 119k |
| PFR_COVID19_200401_Partial unemployment compensates the employee.docx | 2023-03-12 11:15 | 65k |
| PFR_COVID19_200401_Évaluation au 30 mars 2020 de l'impact econmique de la pa... | 2023-03-12 11:15 | 1234k |
| PFR_COVID19_200402_Stanowisko profesorow z Krakowa ws ustawy cowidowej.pdf | 2023-03-12 11:15 | 304k |
| PFR_COVID19_200402_tabela z francuskim szacunkiem spadku po sektorach.xlsx | 2023-03-12 11:15 | 13k |
| PFR_COVID19_200403_Estimating the number of infections and the ... | 2023-03-12 11:15 | 1848k |
| PFR_COVID19_200403_Incubation Period and Other Epidemiological Characteristic... | 2023-03-12 11:15 | 938k |
| PFR_COVID19_200403_Using Behavioral Science to help fight the Coronavirus.pdf | 2023-03-12 11:15 | 668k |
| PFR_COVID19_200404_Correlation betweenuniversal BCG vaccination policy and re... | 2023-03-12 11:15 | 366k |
| PFR_COVID19_200404_expert reaction to questions about COVID-19 and viral load... | 2023-03-12 11:15 | 21k |
| PFR_COVID19_200404_Infective Doses and Pathogen Carriage.pdf | 2023-03-12 11:15 | 534k |
| PFR_COVID19_200404_SARS-CoV-2 viral load and the severity of COVID-19.docx | 2023-03-12 11:15 | 78k |
| PFR_COVID19_200404_Validation of the Wild-type Influenza A Human Challenge Mo... | 2023-03-12 11:15 | 251k |
| PFR_COVID19_200404_Viral dynamics in mild and severe cases of COVID-19.pdf | 2023-03-12 11:15 | 308k |
| PFR_COVID19_200406_cellex serological test Emergency Use Athorization.pdf | 2023-03-12 11:15 | 329k |
| PFR_COVID19_200406_Developing antibody tests for SARS-CoV-2.pdf | 2023-03-12 11:15 | 50k |
| PFR_COVID19_200406_Monitoring the COVID-19 epidemic in the context of widespr... | 2023-03-12 11:15 | 200k |
| PFR_COVID19_200406_Offline COVID-19 what countries must do now.pdf | 2023-03-12 11:15 | 339k |
| PFR_COVID19_200408_Estimates of the severity of coronavirus disease 2019 a mo... | 2023-03-12 11:15 | 877k |
| PFR_COVID19_200417_The effect of public health measures on the 1918 influenza... | 2023-03-12 11:15 | 352k |
| PFR_COVID19_200420_Did California’s Shelter-in-Place Order Work Early Coron... | 2023-03-12 11:15 | 2665k |
| PFR_COVID19_200420_Die volkswirtschaftlichen Kosten des Corona Shutdown für ... | 2023-03-12 11:15 | 980k |
| PFR_COVID19_200420_Estimating false-negative detection rate of SARS-CoV-2 by ... | 2023-03-12 11:15 | 664k |
| PFR_COVID19_200420_How Are Small Businesses Adjusting to COVID-19 Early Evide... | 2023-03-12 11:15 | 1403k |
| PFR_COVID19_200424_DECLINE IN GLOBAL TRANSMISSION RATES OFCOVID-19.pdf | 2023-03-12 11:15 | 426k |
| PFR_COVID19_200424_Estimating the burden of SARS-CoV-2 in France.pdf | 2023-03-12 11:15 | 4339k |
| PFR_COVID19_200424_Indoor transmission of SARS-CoV-2.pdf | 2023-03-12 11:15 | 2001k |
| PFR_COVID19_200424_Outbreak dynamics of COVID-19 in Europe and th eeffects of... | 2023-03-12 11:15 | 6967k |
| PFR_COVID19_200424_Travel restrictions hampering COVID-19 response.pdf | 2023-03-12 11:15 | 454k |
| PFR_COVID19_200504_Considering BCG vaccination to reduce the impact of COVID-... | 2023-03-12 11:15 | 39k |
| PFR_COVID19_200504_COVID-19 deaths in Lombardy, Italy data in contet.pdf | 2023-03-12 11:15 | 41k |
| PFR_COVID19_200504_Impact of contact tracing on SARS-CoV-2 transmission.pdf | 2023-03-12 11:15 | 107k |
| PFR_COVID19_200504_What policy makers need to know about COVID-19 protctiive ... | 2023-03-12 11:15 | 138k |
| PFR_COVID19_200505_First-wave COVID-19 transmissibility and severity in China... | 2023-03-12 11:15 | 1321k |
| PFR_COVID19_200508_The contribution of asymptomatic SARS-CoV-2 infections to ... | 2023-03-12 11:15 | 1151k |
| PFR_COVID19_200511_A Note on Long-Run Persistence of Public Health Outcomes i... | 2023-03-12 11:15 | 715k |
| PFR_COVID19_200512_A rapid review of available evidence on the serial interva... | 2023-03-12 11:15 | 130k |
| PFR_COVID19_200512_Assessment of SARS-CoV-2 replication in the context of oth... | 2023-03-12 11:15 | 138k |
| PFR_COVID19_200512_Chile plans controversial COVID-19 certificates.pdf | 2023-03-12 11:15 | 34k |
| PFR_COVID19_200512_COVID-19 The CIDRAP Viewpoint.pdf | 2023-03-12 11:15 | 4074k |
| PFR_COVID19_200512_COVID19 underlying metabolic health in the spotlight.pdf | 2023-03-12 11:15 | 75k |
| PFR_COVID19_200512_Effective transmission cross te globe the role of climate ... | 2023-03-12 11:15 | 46k |
| PFR_COVID19_200512_Estimating pre-symptomatic transmission of COVID-.pdf | 2023-03-12 11:15 | 269k |
| PFR_COVID19_200512_European Economic Forecast Spring 2020.pdf | 2023-03-12 11:15 | 3388k |
| PFR_COVID19_200512_Offline Independent science advice for COVID19 at last.pdf | 2023-03-12 11:15 | 214k |
| PFR_COVID19_200512_Projecting the transmission dynamics of SARS-COV-2 through... | 2023-03-12 11:15 | 6307k |
| PFR_COVID19_200512_The invisible pandemic.pdf | 2023-03-12 11:15 | 39k |
| PFR_COVID19_200513_HOW DEADLY IS COVID-19 UNDERSTANDING THE DIFFICULTIES WITH... | 2023-03-12 11:15 | 404k |
| PFR_COVID19_200514_1O C C U P A T I O N A L E X P O S U R E T O C O N T A G I... | 2023-03-12 11:15 | 2492k |
| PFR_COVID19_200514_Network frailty and the geometry of herd immunity.pdf | 2023-03-12 11:15 | 207k |
| PFR_COVID19_200514_The airborne lifetime of small speech droplets and their p... | 2023-03-12 11:15 | 596k |
| PFR_COVID19_200515_The Economics of Viral Outbreaks.pdf | 2023-03-12 11:15 | 463k |
| PFR_COVID19_200516_COVID-19 Antibody Seroprevalence in Santa Clara County, Ca... | 2023-03-12 11:15 | 1639k |
| PFR_COVID19_200516_Estimating the burden of SARS-CoV-2 in France.pdf | 2023-03-12 11:15 | 1286k |
| PFR_COVID19_200516_Individual variation in susceptibility or exposure to SARS... | 2023-03-12 11:15 | 1098k |
| PFR_COVID19_200519_A systematic review and meta-analysis of published researc... | 2023-03-12 11:15 | 860k |
| PFR_COVID19_200519_How deadly is COVID-19 A rigorous analysis of excess morta... | 2023-03-12 11:15 | 511k |
| PFR_COVID19_200519_Infection fatality rate of SARS-CoV-2 infection in a Germa... | 2023-03-12 11:15 | 661k |
| PFR_COVID19_200519_Lack of cross neutralization by SARS patient sera towards ... | 2023-03-12 11:15 | 1060k |
| PFR_COVID19_200519_National age and co-residence patterns shape covid-19 vuln... | 2023-03-12 11:15 | 3534k |
| PFR_COVID19_200519_SARS-CoV-2, COVID-19, Infection Fatality Rate (IFR) Implie... | 2023-03-12 11:15 | 928k |
| PFR_COVID19_200519_Serology for SARS-CoV-2 Apprehensions, opportunities, and ... | 2023-03-12 11:15 | 480k |
| PFR_COVID19_200519_Seroprevalence of COVID-19 virus infection in Guilan provi... | 2023-03-12 11:15 | 108k |
| PFR_COVID19_200519_Superspreading and the impact of individual variation Supp... | 2023-03-12 11:15 | 435k |
| PFR_COVID19_200519_Test performance evaluation of SARS-CoV-2 serological assa... | 2023-03-12 11:15 | 1326k |
| PFR_COVID19_200519_The many estimates of the COVID019 case fatality rate.pdf | 2023-03-12 11:15 | 43k |
| PFR_COVID19_200522_A future vaccination campaign against COVID-19 at risk of ... | 2023-03-12 11:15 | 296k |
| PFR_COVID19_200522_Closed environments facilitate secondary transmission of c... | 2023-03-12 11:15 | 108k |
| PFR_COVID19_200522_ESTUDIO ENE-COVID19 PRIMERA RONDA ESTUDIO NACIONAL DE SERO... | 2023-03-12 11:15 | 2019k |
| PFR_COVID19_200522_Novel viruses, old data, and basic principles how to save ... | 2023-03-12 11:15 | 107k |
| PFR_COVID19_200522_Serosurveys and convalescent plasma in COVID-19.pdf | 2023-03-12 11:15 | 251k |
| PFR_COVID19_200524_Remdesivir for the Treatment of Covid-19 — Preliminary R... | 2023-03-12 11:15 | 598k |
| PFR_COVID19_200529_Different pattern of pre-existing SARS-COV-2 specific T ce... | 2023-03-12 11:15 | 4142k |
| PFR_COVID19_200529_orecasting COVID-19 pandemic in Poland according to govern... | 2023-03-12 11:15 | 1238k |
| PFR_COVID19_200529_Revisiting the 1957 and 1968 influenza pandemics.pdf | 2023-03-12 11:15 | 1000k |
| PFR_COVID19_200531_Endothelial cell infection and endotheliitis in COVID-19.pdf | 2023-03-12 11:15 | 403k |
| PFR_COVID19_200531_Estimating the Global Infection Fatality Rate of COVID19.pdf | 2023-03-12 11:15 | 1513k |
| PFR_COVID19_200531_Models of transmission of COVID-19 with time under the inf... | 2023-03-12 11:15 | 1576k |
| PFR_COVID19_200531_Serologic responses to SARS-CoV-2 infection among hospital... | 2023-03-12 11:15 | 403k |
| PFR_COVID19_200531_Targets of T Cell Responses to SARS-CoV-2 in humans with C... | 2023-03-12 11:15 | 3491k |
| PFR_COVID19_200608_Remarkable variability in SARS-CoV-2 antibodies across Bra... | 2023-03-12 11:15 | 666k |
| PFR_COVID19_200608_Seroprevalence of immunoglobulin M and G antibodies agains... | 2023-03-12 11:15 | 1634k |
| PFR_COVID19_200608_The proximal origin of SARS-CoV-2.pdf | 2023-03-12 11:15 | 850k |
| PFR_COVID19_200608_Weekly Coronavirus Disease 2019 (COVID-19) Surveillance Re... | 2023-03-12 11:15 | 3470k |
| PFR_COVID19_200615_Inflation with Covid Consumption Baskets.pdf | 2023-03-12 11:15 | 296k |
| PFR_COVID19_200629_COVID-19 in children and adolescents in Europe a multinati... | 2023-03-12 11:15 | 1146k |
| PFR_COVID19_200629_Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva... | 2023-03-12 11:15 | 234k |
| PFR_COVID19_200705_Exaggerated risk of transmission of COVID-19 by fomites.pdf | 2023-03-12 11:15 | 47k |
| PFR_COVID19_200706_Comparing SARS-CoV-2 with SARS-CoV and influenza.pdf | 2023-03-12 11:15 | 161k |
| PFR_COVID19_200707_Covid-19, cash, and the future of payments.pdf | 2023-03-12 11:15 | 1091k |
| PFR_COVID19_200707_SARS-CoV-2 seroprevalence in COVID-19 hotspots.pdf | 2023-03-12 11:15 | 128k |
| PFR_COVID19_200713_Longitudinal evaluationand declineof antibody responses in... | 2023-03-12 11:15 | 4584k |
| PFR_COVID19_200720_COVID-19 and Implications for Automation.pdf | 2023-03-12 11:15 | 1273k |
| PFR_COVID19_201002_A history of herd immunit.pdf | 2023-03-12 11:15 | 346k |
| PFR_COVID19_201002_Low risk of SARS-CoV-2 transmission by fomites in real-lif... | 2023-03-12 11:15 | 42k |
| PFR_COVID19_201002_SARS-CoV-2 antibody prevalence in Brazil results from two ... | 2023-03-12 11:15 | 572k |
| PFR_COVID19_201002_SARS-CoV-2 antibody seroprevalence in patients receiving d... | 2023-03-12 11:15 | 175k |
| PFR_COVID19_201002_Science and the breakdown of trust.pdf | 2023-03-12 11:15 | 457k |
| PFR_COVID19_201002_What can we expect from first-generation COVID-19 vaccines... | 2023-03-12 11:15 | 139k |
| PFR_COVID19_201009_Assessing the Age Specificityof Infection Fatality Rates f... | 2023-03-12 11:15 | 637k |
| PFR_COVID19_201009_Corticosteroids for COVID-19, Living guidance.pdf | 2023-03-12 11:15 | 541k |
| PFR_COVID19_201009_Genomic evidence for a case of reinfection with SARS-CoV-2... | 2023-03-12 11:15 | 848k |
| PFR_COVID19_201009_Living with the COVID-19 pandemic act now with the tools w... | 2023-03-12 11:15 | 65k |
| PFR_COVID19_201009_Re-infection by a Phylogenetically Distinct Severe Acute R... | 2023-03-12 11:15 | 510k |
| PFR_COVID19_201009_strktura gosp domowych.xlsx | 2023-03-12 11:15 | 67k |
| PFR_COVID19_201012_Absence ofSARS-CoV-2 neutralizingactivity in pre-pandemic ... | 2023-03-12 11:15 | 388k |
| PFR_COVID19_201012_COVID-19 France grapples with the pragmatics of isolation.pdf | 2023-03-12 11:15 | 45k |
| PFR_COVID19_201012_The need for detailed COVID-19 data in Spain.pdf | 2023-03-12 11:15 | 47k |
| PFR_COVID19_201015_False-positive COVID-19 results hidden problems and costs.pdf | 2023-03-12 11:15 | 189k |
| PFR_COVID19_201015_SARS-CoV-2 immunity review and applications to phase 3 vac... | 2023-03-12 11:15 | 895k |
| PFR_COVID19_201015_Scientific consensus on the COVID-19 pandemic we need to a... | 2023-03-12 11:15 | 66k |
| PFR_COVID19_201015_Taking pandemic sequelae seriously from the Russian influe... | 2023-03-12 11:15 | 1046k |
| PFR_COVID19_201015_What reinfections mean for COVID-19.pdf | 2023-03-12 11:15 | 107k |
| PFR_COVID19_201019_Repurposed antiviral drugs for COVID-19 interim WHO SOLIDA... | 2023-03-12 11:15 | 1565k |
| PFR_COVID19_201019_The scientific and ethical feasibility of immunity passpor... | 2023-03-12 11:15 | 91k |
| PFR_COVID19_201019_Weekly COVID-19 testingwith household quarantineand contac... | 2023-03-12 11:15 | 240k |
| PFR_COVID19_201020_Convalescent Plasma for COVID-19 A multicenter, randomized... | 2023-03-12 11:15 | 270k |
| PFR_COVID19_201020_Convalescent Plasma in treatment of COVID-19 A review of e... | 2023-03-12 11:15 | 382k |
| PFR_COVID19_201027_Estimating the COVID-19 R number a bargain with the devil.pdf | 2023-03-12 11:15 | 60k |
| PFR_COVID19_201027_Herd immunity confusion.pdf | 2023-03-12 11:15 | 35k |
| PFR_COVID19_201027_Influnza seasonality lifting the fog.pdf | 2023-03-12 11:15 | 128k |
| PFR_COVID19_201103_Report 34 COVID-19 Infection Fatality Ratio Estimates from... | 2023-03-12 11:15 | 686k |
| PFR_COVID19_201109_Limitations of using mobile phone data to model covid-19 t... | 2023-03-12 11:15 | 49k |
| PFR_COVID19_201109_SARS-CoV-2 seroprevalence and transmission risk factors am... | 2023-03-12 11:15 | 784k |
| PFR_COVID19_201111_Robust neutralizing antibodies to SARS-CoV-2 infection per... | 2023-03-12 11:15 | 994k |
| PFR_COVID19_201111_The engines of SARS-CoV-2 spread.pdf | 2023-03-12 11:15 | 207k |
| PFR_COVID19_201111_The temporal association of introducing and lifting non-ph... | 2023-03-12 11:15 | 963k |
| PFR_COVID19_201116_The UK needs a ustainable strategy for COVID-19.pdf | 2023-03-12 11:15 | 67k |
| PFR_COVID19_210325_Biden's first legislative victory $1·9 trillion for COVID... | 2023-03-12 11:15 | 58k |
| PFR_COVID19_210325_Is the worst of the pandemic over for Europe.pdf | 2023-03-12 11:15 | 236k |
| PFR_COVID19_cost benefit exit_200504_Liberty After Lockdown.pdf | 2023-03-12 11:15 | 237k |
| PFR_COVID19_cost benefit exit_200511_Is the Cure Worse than the Problem Itsel... | 2023-03-12 11:15 | 703k |
| PFR_COVID19_cost benefit exit_200511_The Cost of the Covid-19 Crisis Lockdown... | 2023-03-12 11:15 | 666k |
| PFR_COVID19_cost benefit exit_200512_A Multi-Risk SIR Model with Optimally Ta... | 2023-03-12 11:15 | 790k |
| PFR_COVID19_cost benefit exit_200512_Early impact oftheCOVID-19 pandemic and ... | 2023-03-12 11:15 | 621k |
| PFR_COVID19_cost benefit exit_200512_POLICY IMPLICATIONS OF MODELS OF THE SPR... | 2023-03-12 11:15 | 408k |
| PFR_COVID19_cost benefit exit_200512_The benefits and costs of using social d... | 2023-03-12 11:15 | 658k |
| PFR_COVID19_cost benefit exit_200512_When Do Shelter-in-Place Orders Fight CO... | 2023-03-12 11:15 | 1378k |
| PFR_COVID19_cost benefit exit_200519_Global coordination on cross-border trav... | 2023-03-12 11:15 | 54k |
| PFR_COVID19_cost benefit exit_200522_Accounting for Global COVID-19 Diffusion... | 2023-03-12 11:15 | 974k |
| PFR_COVID19_cost benefit exit_200522_COVID-19 when should quarantine be enfor... | 2023-03-12 11:15 | 81k |
| PFR_COVID19_cost benefit exit_200522_Measuring Real Consumption and CPI Bias ... | 2023-03-12 11:15 | 499k |
| PFR_COVID19_cost benefit exit_200525_Were Urban Cowboys Enough to Control COV... | 2023-03-12 11:15 | 560k |
| PFR_COVID19_cost benefit exit_200529_How did governmental interventions affec... | 2023-03-12 11:15 | 846k |
| PFR_COVID19_cost benefit exit_200529_Stockholm City's Elderly Care and COVID1... | 2023-03-12 11:15 | 848k |
| PFR_COVID19_cost benefit exit_200531_When an emerging disease becomes endemic... | 2023-03-12 11:15 | 559k |
| PFR_COVID19_cost benefit exit_200603_COVID-19 Doesn't Need Lockdowns to Destr... | 2023-03-12 11:15 | 538k |
| PFR_COVID19_cost benefit exit_200603_Deadly Debt Crises COVID-19 in Emerging ... | 2023-03-12 11:15 | 956k |
| PFR_COVID19_cost benefit exit_200603_India's Lockdown An Interim Report.pdf | 2023-03-12 11:15 | 493k |
| PFR_COVID19_cost benefit exit_200629_Estimating the effects of non-pharmaceut... | 2023-03-12 11:15 | 8120k |
| PFR_COVID19_cost benefit exit_200708_Ensuring Uptake of Vaccines against SARS... | 2023-03-12 11:15 | 362k |
| PFR_COVID19_cost benefit exit_210108_DEATHS OF DESPAIR AND THE INCIDENCE OF E... | 2023-03-12 11:15 | 2202k |
| PFR_COVID19_cost benefit exit_210113_Assessing Mandatory Stay‐at‐Home and... | 2023-03-12 11:15 | 9390k |
| PFR_COVID19_cost benefit exit_210113_Inferring the effectiveness of governmen... | 2023-03-12 11:15 | 2527k |
| PFR_COVID19_cost benefit exit_210113_Nonpharmaceutical Influenza Mitigation S... | 2023-03-12 11:15 | 255k |
| PFR_COVID19_cost benefit exit_210115_A tale of two wage subsidiesThe American... | 2023-03-12 11:15 | 295k |
| PFR_COVID19_cost benefit exit_210115_misc notes.pdf | 2023-03-12 11:15 | 122k |
| PFR_COVID19_cost benefit exit_210116_100 dni solidarnosci.pdf | 2023-03-12 11:15 | 3711k |
| PFR_COVID19_cost benefit exit_210201_COVID-19 and SMEs A 2021 Time Bomb.pdf | 2023-03-12 11:15 | 140k |
| PFR_COVID19_cost benefit exit_210202_raport_BGK_narzedzia_pomocowe_COVID_styc... | 2023-03-12 11:15 | 2468k |
| PFR_COVID19_cost benefit exit_210402_COVID-19 Rethinking the Lockdown.pdf | 2023-03-12 11:15 | 1108k |
| PFR_COVID19_cost benefit exit_210402_The declining effectiveness of lockdowns... | 2023-03-12 11:15 | 695k |
| PFR_COVID19_cost benefit exit_210408_The Great Lockdown and the Big Stimulus ... | 2023-03-12 11:15 | 940k |
| PFR_COVID19_cost benefit exit_210421_16 Possible Factors for Sweden’s High ... | 2023-03-12 11:15 | 1590k |
| PFR_COVID19_cost benefit exit_210421_Social Repercussions of Pandemics.pdf | 2023-03-12 11:15 | 1041k |
| PFR_COVID19_cost benefit exit_210505_NBER WORKING PAPER SERIESLONGER-RUN ECON... | 2023-03-12 11:15 | 460k |